Differences in lung bioavailability between different propellants for fluticasone propionate Original Research Article
Author/Authors :
Andrew M Wilson، نويسنده , , Erika J Sims، نويسنده , , Linda C Orr، نويسنده , , Brian J Lipworth، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 1999
Pages :
2
From page :
1357
To page :
1358
Abstract :
The lung bioavailability (as adrenal suppression) of fluticasone propionate was about two-fold greater with chlorofluorocarbons than hydrofluoroalkane as propellant. Direct switching between formulations on a μg equivalent may therefore be inadvisable.
